Baseline patient reported outcomes in patients with peripheral artery disease and type 2 diabetes from STRIDE: a phase 3, 52-week, randomised, double-blind, placebo-controlled trial
1 September 2024 (17:00 - 17:30)
Organised by: 

About the speaker

St. Michael's Hospital, Toronto (Canada)
5 More presentations in this session

Associate Professor L. Virgen Carrillo (Guadalajara, MX)
Access the full session
The Event
ESC Congress 2024
1 September 2024
17:00 CET
You may be interested in
Congress Session
Congress Session




